Skip redundant pieces
39 + Rainbow
It’s a classic Catch-22. What comes first, the research or the funding? How can a research organization convince funders that they should invest in its ideas? Or more to the point, how does the University of Kansas Medical Center secure a bigger piece of the biomedical research pie?

When that question is put to Paul Terranova, PhD, vice chancellor for research at KU Medical Center and president of KUMC’s Research Institute, he replies simply, “Wow the funders with your proposals. You want funders to know that your ideas are so innovative and so important that they MUST be funded.”

Edward Ellerbeck, MD, chair of KU Medical Center’s Department of Preventive Medicine and Public Health, agrees, citing the example of a recent $3 million grant from the National Cancer Institute (NCI) to a KU Medical Center researcher for a smoking cessation project. The researcher was awarded the grant despite the fact that the NCI routinely reviews and rejects hundreds of similar proprosals.

“The data showed that our unique, multi-intervention approach was three times more effective than other stop-smoking programs, and the NCI reviewers were impressed,” says Ellerbeck.

Both Ellerbeck and Terranova agree that the pressure to dazzle funders is mounting. One reason is that interest in biomedical research has soared in recent years, which has led to more competition among researchers. At the same time, research funding from the National Institutes for Health (NIH) and other major government agencies has been flat or declining. Because the competition for research dollars is fierce, funders frequently are forced to reject good research projects in favor of those that appear to be great.